Edition:
India

Genprex Inc (GNPX.OQ)

GNPX.OQ on NASDAQ Stock Exchange Capital Market

2.08USD
18 Mar 2019
Change (% chg)

-- (--)
Prev Close
$2.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,807
52-wk High
$19.40
52-wk Low
$0.95

Chart for

About

Genprex, Inc. is a clinical stage gene therapy company. The Company is focused on developing cancer-based upon its novel proprietary technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. The Company’s Oncoprex is lead product candidate, is the subject of an ongoing Phase I/II... (more)

Overall

Beta: --
Market Cap(Mil.): $--
Shares Outstanding(Mil.): 0.33
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates